Home › Concussion › Washington
Concussion clinical trials in Washington, DC
4 studies for Concussion are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
Recruiting
- Walter Reed National Medical Military Center, Bethesda · 7 mi away
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
RecruitingPhase 3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Clinical Trial Comparing the Efficacy of Two Teletherapy Programs at Improving Psychological Health in People With Brain Injury
Recruiting
- National Intrepid Center Of Excellence, Bethesda · 7 mi away
Post-Concussion Musculoskeletal Injury Risks
RecruitingObservational studyHealthy volunteers welcome
- Walter Reed National Military Medical Center, Bethesda · 7 mi away
About Concussion
Concussion, a minor injury to the brain due to a blow or hit to the head. Symptoms may not show up right away. Learn when to see your doctor.
More about Concussion on MedlinePlus
Concussion trials in other cities
- San Diego, CA6 studies
- San Antonio, TX5 studies
- Dallas, TX4 studies
- Fayetteville, NC4 studies
- Pittsburgh, PA4 studies
- Philadelphia, PA4 studies
- Houston, TX3 studies
- Aurora, CO3 studies
- Seattle, WA3 studies
- Ann Arbor, MI3 studies
- Minneapolis, MN3 studies
- Boston, MA3 studies
Other studies in Washington
- Cancer (all types)60 studies
- Non-Small Cell Lung Cancer54 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Cardiovascular Disease29 studies
- Colorectal Cancer29 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.